Thawing System Market Poised to Expand at a Robust Pace by 2026

Posted by Aman Jaiswar on July 18th, 2019

Thawing systems find application in defrosting biological samples in biobanks, diagnostic centers, and biotechnology and pharmaceutical companies. Thawing systems typically consist of thaw bags and containers for process development. Those are highly useful for research and development processes since they do away with the need for large amount of sample.

General Electric Company, Sartorius Aktiengesellschaft, Helmer, Inc., Cardinal Health, Inc., Cytotherm Lp, Barkey GmbH & Co. KG, and BioCision, LLC. Are to name a few of the key companies operating in the global Thawing System Market.

A report on the market by Transparency Market Research finds that it would rise at a robust 10% CAGR between 2017 and 2026. Rising at this pace, the global thawing systems market would likely reach a valuation of US0 mn by the end of 2026.

Request to View Sample of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=36629

global thawing system marketBased on the type of product, the low cost manual thawing systems are seeing significantly high demand in the global thawing system market. This demand is expected to remain intact over the course of the forecast duration. From a geographical standpoint, North America at present holds a dominant position in the global thawing systems market. It is mainly powered by the U.S. where a large number of pharmaceutical and biotechnology companies are seen pouring money into drug research and development. Helpful government policies has also led to creation of biobanks to ensure proper storage and supply of blood in hospitals and healthcare centers in the U.S. This has also filliped the thawing system market in the region. Our report projects North America’s thawing system market to rise at a CAGR of 11.9% during the forecast period.

Majorly fuelling the global thawing system market is their rising usage in the biopharmaceutical industry. The lead analyst of our report, further elaborates, “Biopharmaceutical companies that are into manufacture of drugs need thawing systems for transporting and storing pharmaceutical products. Further, sterile designs and short process cycles have led to high uptake of thawing systems in end-use industries. Several bio-repositories worldwide are expending large amounts in increasing their storage capacities. All the aforementioned are seen providing a major boost to the global thawing system market.” Thawed cells are also finding application in treating chronic health issues such as cancer and diabetes.